Regencell Bioscience Holdings Limited (RGC) Stock Overview
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit…
Source: Yahoo Finance
Sector & Industry
Regencell Bioscience Holdings Limited operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry group. It is listed on the NASDAQ exchange.
Regencell Bioscience Holdings Limited at a Glance
| Company | Regencell Bioscience Holdings Limited |
| Ticker | RGC |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $6.89 |
| Market cap | $2.72B |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$0.01 |
| 52-week high | $69.00 |
| 52-week low | $4.51 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 1.43 |
| Return on equity (ROE) | -177.66% |
| Debt-to-equity | 31.68% |
| Average volume | 320,352 |
| Shares outstanding | — |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 10 |
| Country | Hong Kong |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Frequently Asked Questions
- What is Regencell Bioscience Holdings Limited's current P/E ratio?
- Regencell Bioscience Holdings Limited (RGC) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Regencell Bioscience Holdings Limited's market capitalisation?
- Regencell Bioscience Holdings Limited's market cap is $2.72B based on our latest snapshot. See how it ranks by market cap →
- What is RGC's 52-week range?
- Over the past 52 weeks, RGC has traded between $4.51 and $69.00. What does the 52-week range mean? →
- How volatile is Regencell Bioscience Holdings Limited compared to the market?
- Regencell Bioscience Holdings Limited has a beta of 1.43, meaning it has historically moved more than the broader market. What does beta measure? →
- Does Regencell Bioscience Holdings Limited pay a dividend?
- Regencell Bioscience Holdings Limited does not currently pay a dividend according to our latest data.
- What exchange is RGC listed on?
- RGC is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Regencell Bioscience Holdings Limited in?
- Regencell Bioscience Holdings Limited is classified in the Healthcare sector. Compare with Healthcare peers →
Need to convert currencies or units alongside this data? Our quick conversion tools are always on hand.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →